AcquisitionOther
Cerevel Therapeutics Holdings, Inc. acquired Cerevel Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Cerevel Therapeutics Holdings, Inc. -> Cerevel Therapeutics · $45.00
The acquisition complements AbbVies neuroscience portfolio, adding a wide range of potentially best-in-class assets that may transform standards of care across psychiatric and neurological disorders where significant unmet needs remain for patients.
Open source record (SEC) ↗